Table 2. Projected effect of pediatric LAIV on adverse health outcomes associated with antibiotic resistance, England and Wales*.
Outcome | Estimate for 2015, England and Wales | Projected reduction in outcome resulting from LAIV, mean (95% HDI) |
---|---|---|
DALYs | 46,039 | 642 (450–842) |
Cases | 47,080 | 432 (303–566) |
Deaths | 1,930 | 22 (16–29) |
*DALYs, disability-adjusted life years; HDI, highest density interval; LAIV, live attenuated influenza vaccine.